Pfizer has announced that they have created a non-prescription version of the Nexium. This is a well-known medicine for those who are suffering heartburns often.
They have already set-up the product on their website, too. It is already available for those who want to order it online. The deal is that they will deliver in a span of three days. Those who need it more often should really allot time. They will have to have some stock on their pantry because three days is quite a long time for anyone with heartburn.
How Is It Going to Go for Heartburners Out There
The pill is packed in a 20 milligram tablet. They have dubbed this as the ‘purple pill’. Usually, those who are suffering from the demise should take this every day for two weeks. This is why Pfizer has put the Nexium in a 14-piece pack.
It will be available in pack of fourteens. Those who would like to stock in their medicine kit will have to buy in bulk. Each of this will cost $15. There will also be a variant available at 40 milligrams at double the price.
Those who would like to take off a dollar in its price can rely to coupons. Pfizer sent out some copies on a website solely designated for this marketing strategy.
Who Did Pfizer Connived With in This Agenda
Astrazaneca will still be the manufacturer of the product. They were the company behind the success of the prescription drug. It will be just wise to leave the job again to them. They say that the new Nexium will take effect 1-4 days after use.
This is longer than the prescription medicine. The previous Nexium has 24HR in its name. This means that it will take effect in just 24 hours. However, it will still come in handy for those who do not have time to go to the doctor and have a legitimate medical request.
Nexium is highly demanded in the market. In 2012, it was named the sixth best-selling drug in the world. It is expected to raise its numbers with this new over-the-counter drug. Also, Pfizer is planning to acquire AstraZaneca for better production. This is believed to be the largest medicinal acquisition, if pushed through.
Will Pfizer be successful in helping more people with the new Nexium? Or will the competition spice up with new competitors coming into play?
